US-based private equity major TPG has agreed to acquire the housing finance arm of Adar Poonawalla-…

Apart from a fresh issue worth up to ₹400 crore, there will be an Offer for Sale (OFS) wherein…

In a tweet, Poonawalla called this cut a "philanthropic gesture" that will save crores of rupees…

Catchphrases don’t cure, actual drugs do. In fact, since 2015, the year when the government…

The investment firm True North (formerly India Value Fund) has sold a part of its stake in Polic…

Some of its popular products include its signature Nutella sea salt, double chocolate chip and cla…

JetSynthesys will use the funding to strengthen its existing catalogue of products and platforms un…

Bengaluru-based edtech startup BYJU’S, which is already the world’s most valued edtech company, is …

"Our manufacturing facility is ready and we plan to start production in two months. We are spendin…

Serum Institute is the other Indian company on the list. TIME listed Reliance in the 'Tita…

Indian equity markets opened in the red on Friday following negative global cues on concerns over g…

"End of the year, we are hoping to have a vaccine. So we will discuss once of the phase three trial…

Hailing from a variety of industry backgrounds, Indian billionaires have helped build the country’s…

World’s largest vaccine manufacturer, the Serum Institute of India (SSI), hopes oxford COVID-19 vac…

The total tally of COVID-19 cases in the country has climbed to 2,02,82,833. Registering a st…

"This will, in turn, help us with reduced capital expenditure and expedited testing," he said.…

The scientific community has stated that they had hinted to the Central government about the new va…

The vaccine that will have to be taken in two doses, will cost less than $10 (₹740) in internati…

Japanese investment firm SoftBank’s Vision Fund 2 has led a $100 million fund in Biofourmis – a dig…

Prashanth Chandrasekar believes India will be “huge powerhouse for software development for compani…